Skip to main content

THERMO FISHER SCIENTIFIC INC

For the period ended Mar 30, 2024. Filed May 3, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 30, 2024 · Filed May 3, 2024

TMO$718.20-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Comprehensive Income

Three months ended
March 30,April 1,
(In millions)20242023
Comprehensive income
Net income$1,331$1,292
Other comprehensive income/(loss):
Currency translation adjustment:
Currency translation adjustment (net of tax provision (benefit) of $166 and $(36))45644
Unrealized gains/(losses) on available-for-sale debt securities
Unrealized holding losses arising during the period (net of tax (provision) benefit of $0 and $0)(1)—
Unrealized gains/(losses) on hedging instruments:
Reclassification adjustment for losses included in net income (net of tax (provision) benefit of $0 and $1)13
Pension and other postretirement benefit liability adjustments:
Pension and other postretirement benefit liability adjustments arising during the period (net of tax (provision) benefit of $0 and $(1))11
Total other comprehensive income/(loss)45748
Comprehensive income1,7881,340
Less: comprehensive income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest16
Comprehensive income attributable to Thermo Fisher Scientific Inc.$1,787$1,334
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.